Skip to content

APOTHEEK QUEENS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK QUEENS

BE 0876.665.709
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€9,737
2024 · €34,071-€43,808
Equity
€311,199
2024 · €317,750-€6,551
Cash
€96,241
2024 · €140,920-€44,678
Balance sheet total
€621,995
2024 · €658,577-€36,582

Largest movements

2024 to 2025
Assets
  • Cash -€44,678

    down €44,678 (-31.7%), from €140,920 to €96,241

    mainly Receivables within one year (-€20,314) and Current portion of long-term debt (-€19,501)

  • Receivables within one year +€20,314

    up €20,314 (+23.1%), from €87,912 to €108,226

    of which Other amounts receivable: +€11,615

  • Tangible fixed assets -€9,641

    down €9,641 (-4.4%), from €217,815 to €208,174

    of which Land and buildings: -€6,289

  • Deferred charges and accrued income -€8,834

    down €8,834 (-45.0%), from €19,651 to €10,816

Equity and liabilities
  • Current portion of long-term debt -€19,501

    no longer reported in 2025 (was €19,501)

  • Trade debts -€10,183

    down €10,183 (-11.8%), from €86,502 to €76,319

  • Profit (loss) carried forward -€8,184

    down €8,184 (-3.0%), from €273,895 to €265,711

  • Tax, wage and social debts +€7,356

    up €7,356 (+71.2%), from €10,339 to €17,695

    of which Remuneration and social security: +€7,784

Income statement
  • Staff costs +€63,612

    up €63,612 (+43.1%), from €147,445 to €211,057

  • Taxes -€12,282

    down €12,282 (-97.4%), from €12,614 to €332

  • Financial charges -€5,140

    down €5,140 (-28.4%), from €18,127 to €12,987

  • Depreciation -€2,732

    down €2,732 (-22.1%), from €12,373 to €9,641

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €34,071
Gross operating margin +€727
Staff costs -€63,612
Depreciation +€2,732
Other operating charges -€282
Financial income -€609
Financial charges +€5,140
Taxes +€12,282
Deferred taxes and other -€186
Result 2025 -€9,737
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€24,363
Investment €0
Financing -€20,315
Cash 2024 €140,920
Net result for the year -€9,737
Depreciation +€9,641
Stocks and contracts -€6,258
Receivables within one year -€20,314
Deferred charges and accrued income +€8,834
Provisions -€3,703
Trade debts -€10,183
Tax, wage and social debts +€7,356
Current portion of long-term debt -€19,501
Short-term financial debts -€4,000
Contributions, distributions and other +€3,186
Cash 2025 €96,241
brings cash intakes cash out
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €658,577 €621,995 -€36,582 -5.6%
Fixed assets 21/28 €217,815 €208,174 -€9,641 -4.4%
Tangible fixed assets 22/27 €217,815 €208,174 -€9,641 -4.4%
Land and buildings 22 €211,636 €205,347 -€6,289 -3.0%
Plant, machinery and equipment 23 €1,996 - -€1,996
Furniture and vehicles 24 €4,183 €2,827 -€1,356 -32.4%
Current assets 29/58 €440,762 €413,821 -€26,941 -6.1%
Stocks and contracts in progress 3 €192,279 €198,537 +€6,258 +3.3%
Stocks 30/36 €192,279 €198,537 +€6,258 +3.3%
Amounts receivable within one year 40/41 €87,912 €108,226 +€20,314 +23.1%
Trade receivables 40 €69,449 €78,147 +€8,699 +12.5%
Other amounts receivable 41 €18,464 €30,079 +€11,615 +62.9%
Cash at bank and in hand 54/58 €140,920 €96,241 -€44,678 -31.7%
Deferred charges and accrued income 490/1 €19,651 €10,816 -€8,834 -45.0%
Total equity and liabilities 10/49 €658,577 €621,995 -€36,582 -5.6%
Equity 10/15 €317,750 €311,199 -€6,551 -2.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €25,256 €26,888 +€1,632 +6.5%
Non-distributable reserves 130/1 €1,860 - -€1,860
Reserves not available under the articles 1311 €1,860 - -€1,860
Tax-exempt reserves 132 €23,396 €25,028 +€1,632 +7.0%
Distributable reserves 133 - €1,860 +€1,860
Profit (loss) carried forward 14 €273,895 €265,711 -€8,184 -3.0%
Provisions and deferred taxes 16 €12,046 €8,343 -€3,703 -30.7%
Deferred taxes 168 €12,046 €8,343 -€3,703 -30.7%
Amounts payable 17/49 €328,781 €302,453 -€26,327 -8.0%
Amounts payable within one year 42/48 €328,781 €302,453 -€26,327 -8.0%
Current portion of amounts payable after more than one year 42 €19,501 - -€19,501
Financial debts 43 €204,000 €200,000 -€4,000 -2.0%
Credit institutions 430/8 €204,000 €200,000 -€4,000 -2.0%
Trade debts 44 €86,502 €76,319 -€10,183 -11.8%
Suppliers 440/4 €86,502 €76,319 -€10,183 -11.8%
Taxes, remuneration and social security 45 €10,339 €17,695 +€7,356 +71.2%
Taxes 450/3 €515 €88 -€428 -83.0%
Remuneration and social security 454/9 €9,823 €17,607 +€7,784 +79.2%
Other amounts payable 47/48 €8,439 €8,439 = 0.0%
Non-recurring operating income 76A €966 - -€966
Remuneration, social security and pensions 62 €147,445 €211,057 +€63,612 +43.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,373 €9,641 -€2,732 -22.1%
Other operating charges 640/8 €3,280 €3,562 +€282 +8.6%
Gross operating margin 9900 €225,215 €225,942 +€727 +0.3%
Operating profit (loss) 9901 €62,116 €1,682 -€60,435 -97.3%
Financial income 75/76B €1,991 €1,382 -€609 -30.6%
Recurring financial income 75 €1,991 €1,382 -€609 -30.6%
Financial charges 65/66B €18,127 €12,987 -€5,140 -28.4%
Recurring financial charges 65 €18,127 €12,987 -€5,140 -28.4%
Profit (loss) for the period before taxes 9903 €45,981 -€9,923 -€55,904
Transfer from deferred taxes 780 €704 €518 -€186 -26.4%
Income taxes 67/77 €12,614 €332 -€12,282 -97.4%
Profit (loss) for the period 9904 €34,071 -€9,737 -€43,808
Transfer from tax-exempt reserves 789 €1,367 €1,553 +€186 +13.6%
Profit (loss) for the period to be appropriated 9905 €35,438 -€8,184 -€43,621

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.